Keith Katkin Syndax Pharmaceuticals Inc (SNDX) insider trading activity
Keith Katkin is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 90,000 shares of SNDX, which is worth approximately $1.21 Million. The most recent transaction as insider was on Feb 05, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
90K
38.46%
3M change
38.46%
12M change
Total Value Held
$1.21 Million
Keith Katkin Transaction History
Also insider at
KK
Keith Katkin
Gaithersburg, MD